Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle-and large-T antigens

This publication has 13 references indexed in Scilit:

• Vaccination against polyoma virus (PYV) tumors using vaccinia-PYV recombinants: A major tumor-specific transplantation antigen (TSTA) epitope resides within the C-terminal segment of middle-T protein
  International Journal of Cancer, 1990
• A single peptide derived from the sequence common to polyoma small and middle t-antigen induces immunity against polyoma tumors
  Virology, 1989
• Immunization against the polyoma tumor‐specific transplantation antigen (TSTA) with polyoma T‐antigens
  International Journal of Cancer, 1988
• Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.
  The Journal of Experimental Medicine, 1987
• Tumour prevention and rejection with recombinant vaccinia
  Nature, 1987
• Low responder MHC alleles for Tc recognition of influenza nucleoprotein
  Immunogenetics, 1986
• T-cell antigenic sites tend to be amphipathic structures.
  Proceedings of the National Academy of Sciences, 1985
• General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
  Proceedings of the National Academy of Sciences, 1985
• Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA) - does middle or large T-antigen play a role?
  International Journal of Cancer, 1984
• Polyoma Virus - A Study of Wild-type, Mutant and Defective DNAs
  Published by Cold Spring Harbor Laboratory ,1974